Literature DB >> 8403494

Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE).

H Groen1, M Aslander, H Bootsma, T W van der Mark, C G Kallenberg, D S Postma.   

Abstract

We examined the relationship between peripheral blood and bronchoalveolar lavage (BAL) lymphocyte phenotypes and lung function in 19 patients with SLE, and evaluated their association with disease activity. Lung function assessment showed a mildly restrictive pattern with frequent impairment of transfer factor for carbon monoxide (T1,co) and diffusing capacity of the alveolocapillary membrane (Dm), of late-expiratory airflow rates and with a high prevalence of increased airway resistance. T1,co, Kco and Dm correlated inversely with the numbers of CD8+ cells and CD56+/CD16+/CD3- (NK) cells in BAL. Oxygen radical production, both by stimulated and unstimulated BAL cells and blood polymorphonuclear leucocytes (PMN) was significantly increased in SLE. In comparison with healthy controls, patients with SLE had a lower percentage of CD19+ B cells in the BAL versus an increased percentage of these cells in peripheral blood. HLA-DR expression on CD4+ and CD8+ lung lymphocytes was markedly increased in SLE. Current SLE disease activity was not associated with changes in BAL or peripheral blood lymphocyte phenotypes. Our data suggest that an ongoing cell-mediated immune response is present in the lungs in SLE, particularly involving activated CD8+ T cells and CD56+/CD16+/CD3- NK cells. It is associated with up-regulated local production of oxygen radicals and with impaired pulmonary diffusing capacity. This inflammatory process seems to be independent of general SLE disease activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403494      PMCID: PMC1534354          DOI: 10.1111/j.1365-2249.1993.tb05989.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  NIH conference. Systemic lupus erythematosus: evolving concepts.

Authors:  J L Decker; A D Steinberg; J L Reinertsen; P H Plotz; J E Balow; J H Klippel
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

Review 2.  Subclinical alveolitis in immunological systemic disorders. Transition between health and disease?

Authors:  B Wallaert; M Dugas; E Dansin; T Perez; C H Marquette; P Ramon; A B Tonnel; C Voisin
Journal:  Eur Respir J       Date:  1990-11       Impact factor: 16.671

3.  Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction.

Authors:  D S Postma; T E Renkema; J A Noordhoek; H Faber; H J Sluiter; H Kauffman
Journal:  Am Rev Respir Dis       Date:  1988-01

4.  In vivo demonstration of microvascular pathology by intravital microscopy in experimental chronic graft-versus-host disease: analogy with scleroderma.

Authors:  G Bos; G Majoor; D Slaaf; R Reneman; P van Breda Vriesman
Journal:  J Rheumatol       Date:  1988-09       Impact factor: 4.666

5.  Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study.

Authors:  L P Pertschuk; L F Moccia; Y Rosen; H Lyons; C M Marino; A A Rashford; C M Wollschlager
Journal:  Am J Clin Pathol       Date:  1977-11       Impact factor: 2.493

6.  Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.

Authors:  G R Owens; I L Paradis; S Gryzan; T A Medsger; W P Follansbee; H A Klein; J H Dauber
Journal:  J Lab Clin Med       Date:  1986-03

7.  Immunopathologic studies of pneumonitis in systemic lupus erythematosus.

Authors:  T Inoue; Y Kanayama; A Ohe; N Kato; T Horiguchi; M Ishii; K Shiota
Journal:  Ann Intern Med       Date:  1979-07       Impact factor: 25.391

8.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

9.  Pulmonary function of nonsmoking patients with systemic lupus erythematosus.

Authors:  A P Andonopoulos; S H Constantopoulos; V Galanopoulou; A A Drosos; N C Acritidis; H M Moutsopoulos
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

10.  Experimental immune complex disease of the lung. The pathogenesis of a laboratory model resembling certain human interstitial lung diseases.

Authors:  J R Brentjens; D W O'Connell; I B Pawlowski; K C Hsu; G A Andres
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

2.  Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.

Authors:  P E Spronk; E J ter Borg; M G Huitema; P C Limburg; C G Kallenberg
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

Review 3.  CD8+ T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease.

Authors:  Anna Radziszewska; Zachary Moulder; Elizabeth C Jury; Coziana Ciurtin
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

4.  Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis.

Authors:  Agnieszka Nielepkowicz-Goździńska; Wojciech Fendler; Ewa Robak; Lilianna Kulczycka-Siennicka; Paweł Górski; Tadeusz Pietras; Ewa Brzeziańska; Adam Antczak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-02-04       Impact factor: 4.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.